Conjunctivitis other imaging findings

Jump to navigation Jump to search

Conjunctivitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Conjunctivitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Conjunctivitis other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Conjunctivitis other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Conjunctivitis other imaging findings

CDC on Conjunctivitis other imaging findings

Conjunctivitis other imaging findings in the news

Blogs on Conjunctivitis other imaging findings

Directions to Hospitals Treating Conjunctivitis

Risk calculators and risk factors for Conjunctivitis other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

There are no other imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used to obtain a distinct picture of the entire everted inferior tarsal plate in a patient with keratoconjunctivitis sicca (dry eye syndrome).[1][2]

Other Imaging Findings

There are no other imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used in a patient with keratoconjunctivitis sicca (dry eye syndrome)[2] [3]

Kertoconjunctivitis Sicca

Dynamic Meibomian Imaging

Dynamic meibomian imaging (DMI) provides a distinct picture of the entire everted inferior tarsal plate, allowing both the clinician and the patient to assess the extent of meibomian gland dysfunction.[1][2]

References

  1. 1.0 1.1 Qazi Y, Aggarwal S, Hamrah P (2014). "Image-guided evaluation and monitoring of treatment response in patients with dry eye disease". Graefes Arch Clin Exp Ophthalmol. 252 (6): 857–72. doi:10.1007/s00417-014-2618-2. PMC 4038672. PMID 24696045.
  2. 2.0 2.1 2.2 Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD". Invest Ophthalmol Vis Sci. 52 (4): 1994–2005. doi:10.1167/iovs.10-6997e. PMC 3072161. PMID 21450917.
  3. Azari AA, Barney NP (2013). "Conjunctivitis: a systematic review of diagnosis and treatment". JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.

Template:WS Template:WH